XML 66 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of fair value hierarchy of liabilities measured at fair value on recurring basis

 

 

 

2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Notes payable

 

$

736

 

 

$

 

 

$

 

 

$

736

 

Common stock warrant liability

 

 

 

 

 

 

 

 

474

 

 

$

474

 

Clene Nanomedicine contingent earn-out

 

 

 

 

 

 

 

 

18,100

 

 

$

18,100

 

Initial Stockholders contingent earn-out

 

 

 

 

 

 

 

 

2,317

 

 

$

2,317

 

 

 

 

2020

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Notes payable

 

$

1,296

 

 

$

 

 

$

 

 

$

1,296

 

Clene Nanomedicine contingent earn-out

 

 

 

 

 

 

 

 

52,053

 

 

$

52,053

 

Initial Stockholders contingent earn-out

 

 

 

 

 

 

 

 

5,906

 

 

$

5,906

 

Schedule of unobservable inputs to the conversion feature, warrant liability, and contingent earn-out valuation models

 

 

 

2021

 

Expected stock price volatility

 

 

105.00

%

Risk-free interest rate

 

 

0.70

%

Expected dividend yield

 

 

0.00

%

Expected term

 

2.39 years

 

 

 

 

2021

 

Expected stock price volatility

 

 

105.00

%

Risk-free interest rate

 

 

1.20

%

Expected dividend yield

 

 

0.00

%

Expected term

 

3.89 – 4.39 years

 

 

 

 

2021

 

 

2020

 

Expected stock price volatility

 

 

105.00

%

 

 

85.00

%

Risk-free interest rate

 

 

1.10

%

 

 

0.40

%

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

Expected term

 

4.00 years

 

 

5.00 years

 

 

Schedule of changes in fair value of financial liabilities related to the notes payable, the derivative instrument, the preferred stock warrants, and the contingent earn-outs

 

(in thousands)

 

Notes
Payable

 

 

Derivative Instrument

 

 

Preferred
Stock Warrant Liability

 

 

Common Stock Warrant
Liability

 

 

Clene Nanomedicine
Contingent
Earn-out

 

 

Initial
Stockholders
Contingent
Earn-out

 

Balance - December 31, 2019

 

$

640

 

 

$

 

 

$

3,213

 

 

$

 

 

$

 

 

$

 

Issuance of convertible promissory notes

 

 

 

 

 

705

 

 

 

 

 

 

705

 

 

 

 

 

 

 

Initial fair value of instrument

 

 

 

 

 

 

 

 

 

 

 

 

 

 

64,712

 

 

 

7,371

 

Change in fair value

 

 

656

 

 

 

(29

)

 

 

14,615

 

 

 

(29

)

 

 

(12,659

)

 

 

(1,465

)

Extinguishment of preferred stock warrant liability in connection with the conversion of redeemable convertible preferred stock

 

 

 

 

 

 

 

 

(17,828

)

 

 

 

 

 

 

 

 

 

Extinguishment of derivative liability in connection with extinguishment of the 2020 Convertible Notes (Note 12)

 

 

 

 

 

(676

)

 

 

 

 

 

(676

)

 

 

 

 

 

 

Balance - December 31, 2020

 

$

1,296

 

 

$

 

 

$

 

 

$

 

 

$

52,053

 

 

$

5,906

 

Initial fair value of instrument

 

 

 

 

 

 

 

 

 

 

 

1,457

 

 

 

 

 

 

 

Change in fair value

 

 

(560

)

 

 

 

 

 

 

 

 

(983

)

 

 

(33,953

)

 

 

(3,589

)

Balance - December 31, 2021

 

$

736

 

 

$

 

 

$

 

 

$

474

 

 

$

18,100

 

 

$

2,317